FMW Media's New to The Street, a nationally broadcasted TV show,
announces episode 543, airing on the Fox Business Network, Monday,
January 8, 2024, at 10:30 PM PT.
New to The Street's 543rd TV episode line-up features the
following four (4) Corporate interviews:
1). Biopharmaceutical – Acurx Pharmaceuticals, Inc.'s
(NASDAQ: ACXP) ($ACXP) interview with David Luci,
President/CEO.
2). "Game Changers Segment" interview with Dr.
Navjit Dhaliwal, CEO, IAGON (CRYPTO: IAG) ($IAG)
3). GOLD – Glint Pay's interview with Jason Cozens, CEO.
4). "Sekur Privacy & Sekur Security – Weekly
Hack" segment with internet privacy expert Mr. Alain
Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR)
(FRA: GDT0) (Sekur®).
Episode 543
New to The Street's TV Host Jane King from the Nasdaq MarketSite
Studio talks with David Luci, the President/CEO of Acurx
Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage
biopharmaceutical business, ACXP is developing a new class of
antibiotics for life-threatening bacterial infections. David
updates viewers on the Company's FDA Phase 2 clinical trial
on the Ibezapolstat drug, a treatment for patients with
Clostridioides difficile Infections (CDI). Based on positive data
from Phase 2a and Phase 2b, management is now going forward with
the FDA Phase 3. The Company compared its top-line data with the
currently used standard-of-care drugs in the marketplace, and
Ibezapolstat has impressive positive results. Phases 2a and 2b
confirmed that the drug had success in 25 out of 26 patients,
approximately 96% success with no reinfections. Competitor drugs
have been used for decades to treat CDI, but the reinfection rates
are very high. ACXP's Ibezapolstat study results have shown to
combat reinfections effectively. Based on the data and other
publications regarding the market size for newly discovered and
effective treatment of CDI, ACXP believes Ibezapolstat could be a
market worth over $1B. David explains how the Company will fund its
FDA Phase 3 study and, upon successful approval, will leverage
data/results for future approval(s) with the European Medicines
Agency. Decades-old antibacterial drugs are not working due to
changes in the molecular composition of CDI. Thousands of people
worldwide die annually, with many catching CDI in hospitals and
nursing homes. Acurx Pharmaceuticals, Inc. believes its
Ibezapolstat drug is the next generation for effectively treating
CDI. The on-screen QR code is available during the show; download
or visit Acurx Pharmaceuticals,
Inc. - https://www.acurxpharma.com/.
New to The Street airs its "Game Changers
Segment" with TV Host and Multi-media Journalist Ana
Berry, who talks with Dr. Navjit Dhaliwal, CEO
of IAGON (CRYPTO: IAG) ($IAG). IAGON is a "Game
Changer" in the data compliance and storage industries with
innovative decentralized blockchain technology solutions. Navjit
talks about the global data breaches occurring in all industry
types and how they happen. IAGON is a decentralized cloud storage
solution with no single server holding data. "Big Tech" providers
maintain a single server and a single file, so hackers steal
clients' data when a cybersecurity breach occurs. IAGON is
different; it slices data with multiple redundancies, is held on a
secure and protected blockchain on numerous cloud servers. These
location "Nodes" have several different data matrixes to meet
clients' data storage and management needs. As a fully protected
service, clients can choose performance options with locations in
the USA, Norway, and elsewhere. IAGON blockchain data services
improve users with operational sovereignty over data. With IAGON,
data is in the client's control, no longer given to large "Big
Tech" platforms without consent or fees. With layered encryption
protocols, IAGON's decentralized blockchain data creates an
ecosystem that can assist in many computer industries. AI, machine
learning, and other technology platforms can benefit from adopting
the IAGON platform. Navjit likens IAGON to Airbnb for data storage
and management. With worldwide cybersecurity concerns magnified,
all industries seek ways to protect themselves from data breaches.
IAGON's decentralized blockchain data management ecosystem provides
for multiple industries and uses, ensuring complete data
protection, integrity, and efficiency. The on-screen QR code is
available during the show; download or visit Iagon -
https://iagon.com/.
New to The Street's TV Host Jane King talks with Jason Cozens,
CEO of Glint Pay, discussing how the Company's GOLD payment
platform works and its significance concerning current worldwide
economic issues. The invention of Glint is to liberate everyone
from the current global monetary system. The Glint Pay App is the
only worldwide payment platform that uses allocated GOLD for
everyday purchases. GOLD commodity prices are up, and Jason expects
higher prices due to the economic and inflationary problems
globally. Banking failures, US Treasury devaluations, and
geopolitical conflicts increase prices. The US dollar and other
fiat currencies have lost significant purchasing power over the
past few decades. GOLD has and will continue to maintain its stored
value, having done so for the last 2000 years. Jason explains that
the US Constitution allows states to use gold and silver as
payment. A handful of US states are considering using precious
metals as an alternative to dollars. Glint Pay sees a huge
opportunity, believing its platform could assist these US State
governments in an easy-to-integrate platform, using GOLD as payment
for State operations. The Glint Pay App works where account holders
can buy, sell, save, spend, and send a GOLD holding using the debit
Glint Pay MasterCard, an answer to overcoming financial
insecurities in a turbulent world. Glint Pay account holders' GOLD
holdings are in safes in Switzerland and insured through Lloyd's of
London. Download the app to buy, save, spend, and send real GOLD
and defend yourselves from macro-financial issues. The on-screen QR
code is available during the show; download or visit Glint Pay -
https://glintpay.com/us.
Internationally acclaimed internet privacy expert Alain Ghiai,
CEO, Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0)
(Sekur®) and New to The Street TV Host / Multi-media Journalist Ana
Berry present the "Sekur Privacy & Sekur Security – The
Weekly Hack" segment. Ana and Alain discuss the topic of
the recent hacking and the theft of data at well-known casino
properties, Caesars Entertainment and MGM Resorts. The
hack occurred from a source in the USA, and the FBI is still
investigating the crime. Alain says casino data is valuable,
providing information like names, addresses, hotel stay
particulars, and other private info. Most likely, the hackers are
selling stolen data on the "Dark Web." Even if you haven't been to
these Las Vegas properties recently, data from years ago was
probably on the servers when stolen. At the onset, it looked like
the hack came from an email; casinos and other businesses,
unfortunately, use open-source email platforms. The best option is
to have a secure Sekur Private Data Ltd email platform. Sekur
offers a new product, SekurRelay, software that allows management
and other C-suite executives a private and secure email
communication platform. Unique to Sekur, the product enables
splitting a business domain, allowing emails on Sekur's platform
without limiting the domain's other emails on other platforms. The
product comes with SekurMail's SekurSend/SekurReply feature
that invites electronic communication on Sekur's closed-loop
encrypted platform. The recipient must not be a Sekur subscriber to
enjoy the security and privacy features of the product. Subscribers
can send emails with time limits, password protection, and other
time-out features to enhance privacy for themselves and the
recipient. SekurMail has two alias email addresses used for general
emails, not for transmitting private data. Alain also recommends
its SekurVPN services, which allows end-users to appear always as
operating in Switzerland, masking a subscriber's internet
footprint. IP addresses are private under Swiss privacy laws. Any
data mining or reselling of information is a significant violation
in Switzerland, the strictest privacy law in the world. Alain again
informs viewers that Sekur Private Data, Ltd. wholly owns and
controls its Swiss base servers, never sells data, never mines
data, never asks for phone numbers, never uses 3rd party providers,
and never tracks internet traffic. The Company is offering
PROMO CODE: PRIVACY that gives 15% savings toward
monthly and yearly subscriptions to any of its services. Viewers,
please tune in next time for the newest cybersecurity topic on the
"Sekur Privacy & Sekur Security– Weekly Hack"
segment. The on-screen QR code is available during the shows to
download more info or visit Sekur Private Data, Ltd. –
https://sekurprivatedata.com/, http:/sekur.com/ and
https://sekur.com/en/vpn. Privacy has arrived!
About Acurx Pharmaceuticals, Inc.
(NASDAQ: ACXP) ($ACXP):
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP)
($ACXP) is a clinical-stage
biopharmaceutical Company focused on developing new
antibiotics for difficult-to-treat infections. The Company's
approach is to develop antibiotic candidates that target the DNA
polymerase IIIC enzyme. Its R&D pipeline includes antibiotic
product candidates that target Gram-positive bacteria, including
Clostridioides difficile, methicillin-resistant Staphylococcus
aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and
drug-resistant Streptococcus pneumoniae (DRSP). The Company's
Ibezapolstat is a novel, orally administered antibiotic developed
as a Gram-Positive Selective Spectrum (GPSS™) antibacterial.
It is the first of a new class of DNA polymerase IIIC inhibitors
under development by Acurx to treat bacterial infections.
Ibezapolstat's unique spectrum of activity, which includes C.
difficile but spares other Firmicutes and the important
Actinobacteria phyla, appears to contribute to maintaining a
healthy gut microbiome. The Company completed Phase 2 clinical
trials of Ibezapolstat. To learn more about Acurx
Pharmaceuticals and its product pipeline, please
visit www.acurxpharma.com.
About IAGON (CRYPTO:
IAG) ($IAG):
IAGON was founded in 2017 in Hamar, Norway because people need
to be in control of their data. The idea started as an attempt to
solve significant issues related to how healthcare data is stored,
with modern solutions severely lacking transparency for individuals
at a national and international level. The initial ambition of
IAGON was to create a secure way for individuals to hold and
thereby own their health data and interact more effectively with
health services. IAGON aims to build a marketplace for
decentralized storage and computing resources. The first version of
the protocol will implement a storage marketplace to make joining
the shared storage economy simple and transparent for everyone. The
protocol will allow storage providers to earn rewards by trading
their excess storage to resource consumers on a marketplace at a
transparent price while ensuring data privacy, security, and
accessibility. Its token-based economy is based on computer,
server, and data center owners who join the storage and processing
power grids. In return for sharing the capabilities of their
machine, they will be granted IAGON tokens that can be traded back
to fat money, while any party who wishes to utilize their
capabilities will purchase tokens to distribute them to the parties
that provide their services to the blockchain grid
- https://iagon.com/.
About Glint Pay:
Glint Pay allows the client to choose a monetary position in
currency or gold as money. Clients can buy, save, exchange, and
spend global currencies and gold at cheaper rates than banks. Glint
is reliable and gives you more financial choices and more freedom.
In addition to Glint Pay's ground-breaking gold currency, their app
offers clients the freedom to save in USD and gold. Clients can
exchange between them in seconds, on the move, and always get the
real exchange rate and low, transparent fees. Use the Glint card to
spend the money saved in wallets in more than 150 currencies
anywhere around the world that accepts Mastercard with only a 0.5%
transaction fee. Glint is an Electronic Money Institution
authorized by the Financial Conduct Authority (FAC) in the United
Kingdom - https://glintpay.com/en_us/.
About Sekur Private Data
Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0)
($SWISF):
Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA:
GDT0) ($SWISF) is a cybersecurity and internet privacy provider of
Swiss-hosted solutions for secure communications and secure data
management. The Company distributes a suite of secure cloud-based
storage, disaster recovery, document management, encrypted emails,
and secure communication tools. It sells its products through its
websites, www.sekur.com, approved distributors, and
telecommunication companies worldwide. Sekur Private Data, Ltd.
serves consumers, businesses, and governments worldwide -
https:/sekurprivatedata.com and https://sekur.com;
Twitter: @sekurprivate.
About New to The
Street:
New to The Street is an FMW Media production that operates one
of the longest-running US and International sponsored and
syndicated Nielsen-rated programming television brands, "New to The
Street." Since 2009, New to The Street has run biographical
interview segment shows across major U.S. television networks. The
Nielsen-rated and sponsored broadcast programming platform reaches
millions of homes in the US and international markets. FMW's New to
The Street show appears on Bloomberg and the FOX Business Network
as sponsored programming. FMW is also one of the nation's largest
buyers of linear television, long and short-form paid programming.
Interviews are also available on New to The Street's YouTube
channel @NewtotheStreetTV - https://www.newtothestreet.com/.
Forward-Looking Statements Disclaimer
US/Canada:
This press release contains forward-looking statements within
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology. However, not all
forward-looking statements contain these words. Forward-looking
statements do not guarantee future performance or results and will
not necessarily be accurate indications of when such performance or
results are achieved. This press release should be considered in
all filings of the Companies contained in the Edgar Archives of the
Securities and Exchange Commission at www.sec.gov.
This press release contains forward-looking information within
the meaning of applicable Canadian securities laws. Forward-looking
information is often, but not always, identified by the use of
words such as "seek," "anticipate," "believe," "plan," "estimate,"
"expect," "likely," and "intend" and statements that an event or
result "may," "will," "should," "could" or "might" occur or be
achieved and other similar expressions. These statements reflect
management's current beliefs and are based on information currently
available to management as of the date hereof. Forward-looking
information in this press release includes, without limiting, the
foregoing expectations. Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
CONTACT:
FMW Media Contact:Monica
Brennanmonica@NewtoTheStreet.com1-917-330-2564
"New to The Street" Business Development
Office1-516-696-5900Support@NewToTheStreet.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/b1b16941-e9ed-4223-85d9-f6049bd0b917
Acurx Pharmaceuticals (NASDAQ:ACXP)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Acurx Pharmaceuticals (NASDAQ:ACXP)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024